{"id":10374,"date":"2025-04-08T09:01:06","date_gmt":"2025-04-08T09:01:06","guid":{"rendered":"https:\/\/wallstwarroom.com\/uncategorized\/novos-wegovy-and-jjs-tremfya-lead-pharmaceutical-ad-spending-surge-during-march-madness\/"},"modified":"2025-04-08T09:01:06","modified_gmt":"2025-04-08T09:01:06","slug":"novos-wegovy-and-jjs-tremfya-lead-pharmaceutical-ad-spending-surge-during-march-madness","status":"publish","type":"post","link":"https:\/\/wallstwarroom.com\/h\/pharma-stocks\/novos-wegovy-and-jjs-tremfya-lead-pharmaceutical-ad-spending-surge-during-march-madness\/","title":{"rendered":"Novo&#8217;s Wegovy and J&#038;J&#8217;s Tremfya Lead Pharmaceutical Ad Spending Surge During March Madness"},"content":{"rendered":"<h1>Novo\u2019s Wegovy, J&#038;J\u2019s Tremfya Boost TV Ad Spending During March Madness<\/h1>\n<p>In a notable shift in advertising dynamics within the pharmaceutical sector, Novo Nordisk\u2019s publicity surge for its obesity treatment, Wegovy, alongside Johnson &#038; Johnson\u2019s enhanced spending for Tremfya, is indicative of a strategic pivot towards engaging audiences during the historically significant March Madness basketball tournament. Recent data reveals that the top ten pharmaceutical spenders collectively allocated an impressive $248 million on TV drug advertising in March, representing a harmonious balance between January&#8217;s soaring $302.5 million and February&#8217;s sharp drop to $204.5 million.<\/p>\n<h2>Change in Spending Trends<\/h2>\n<p>The current trends reveal a significant transformation in the advertising landscape for the pharmaceutical industry. Last year, AbbVie\u2019s Skyrizi and Rinvoq dominated the TV ad spending rankings, securing the top positions consistently. However, the first quarter of 2025 has painted a different picture. The two AbbVie products have only managed to achieve top-two monthly rankings on one occasion thus far, representing a stark contrast to their stronghold in early 2024.<\/p>\n<p>In both January and March of 2025, Skyrizi and Rinvoq have slipped to third and fourth positions respectively, overtaken by Novartis\u2019 Pluvicto and Johnson &#038; Johnson\u2019s Tremfya in January and more recently by Novo Nordisk\u2019s Wegovy and Tremfya again in March.<\/p>\n<h2>March\u2019s Top Ad Spenders<\/h2>\n<p>Leading the charge in ad spending for March were:<\/p>\n<h3>1. Wegovy by Novo Nordisk<\/h3>\n<ul>\n<li><strong>Estimated National TV Ad Spend:<\/strong> $40.4 million (up from $25.8 million in February)<\/li>\n<li><strong>Number of Spots:<\/strong> 1<\/li>\n<li><strong>Biggest-ticket Ad:<\/strong> \u201cDiscover the Power: $0\u201d (Estimated spend: $40.4 million)<\/li>\n<\/ul>\n<h3>2. Tremfya by Johnson &#038; Johnson<\/h3>\n<ul>\n<li><strong>Estimated National TV Ad Spend:<\/strong> $32.6 million (up from $20.1 million in February)<\/li>\n<li><strong>Number of Spots:<\/strong> 4 (one ulcerative colitis, three psoriasis)<\/li>\n<li><strong>Biggest-ticket Ad:<\/strong> \u201cBreak Away\u201d (Estimated spend: $23.3 million)<\/li>\n<\/ul>\n<h3>3. Rinvoq by AbbVie<\/h3>\n<ul>\n<li><strong>Estimated National TV Ad Spend:<\/strong> $29.2 million (down from $34.8 million in February)<\/li>\n<li><strong>Number of Spots:<\/strong> 5 (two eczema, two UC\/Crohn\u2019s, one arthritis)<\/li>\n<li><strong>Biggest-ticket Ad:<\/strong> \u201cJust Okay: Jet Ski\u201d (Estimated spend: $11.7 million)<\/li>\n<\/ul>\n<h3>4. Skyrizi by AbbVie<\/h3>\n<ul>\n<li><strong>Estimated National TV Ad Spend:<\/strong> $27.9 million (up from $27 million in February)<\/li>\n<li><strong>Number of Spots:<\/strong> 6 (four psoriasis, one Crohn\u2019s\/UC, one psoriatic arthritis)<\/li>\n<li><strong>Biggest-ticket Ad:<\/strong> \u201cIn the Picture\u201d (Estimated spend: $15.1 million)<\/li>\n<\/ul>\n<h3>5. Rexulti by Lundbeck and Otsuka<\/h3>\n<ul>\n<li><strong>Estimated National TV Ad Spend:<\/strong> $26.2 million (up from $19.3 million in February)<\/li>\n<li><strong>Number of Spots:<\/strong> 2 (one depression, one Alzheimer\u2019s)<\/li>\n<li><strong>Biggest-ticket Ad:<\/strong> \u201cStill Masking: Garage and Office\u201d (Estimated spend: $18.1 million)<\/li>\n<\/ul>\n<h3>6. Ozempic by Novo Nordisk<\/h3>\n<ul>\n<li><strong>Estimated National TV Ad Spend:<\/strong> $21.7 million (up from $10.6 million in February)<\/li>\n<li><strong>Number of Spots:<\/strong> 3<\/li>\n<li><strong>Biggest-ticket Ad:<\/strong> \u201cTestimonials: Michael and Tanya\u201d (Estimated spend: $16.1 million)<\/li>\n<\/ul>\n<h3>7. Dupixent by Sanofi and Regeneron<\/h3>\n<ul>\n<li><strong>Estimated National TV Ad Spend:<\/strong> $20.9 million (down from $22.4 million in February)<\/li>\n<li><strong>Number of Spots:<\/strong> 6 (two asthma, four eczema)<\/li>\n<li><strong>Biggest-ticket Ad:<\/strong> \u201cKenny\u201d (Estimated spend: $7.9 million)<\/li>\n<\/ul>\n<h3>8. Zepbound by Eli Lilly<\/h3>\n<ul>\n<li><strong>Estimated National TV Ad Spend:<\/strong> $19 million (up from $8.4 million in February)<\/li>\n<li><strong>Number of Spots:<\/strong> 4<\/li>\n<li><strong>Biggest-ticket Ad:<\/strong> \u201cChange: What\u2019s Possible\u201d (Estimated spend: $13.8 million)<\/li>\n<\/ul>\n<h3>9. Jardiance by Eli Lilly and Boehringer Ingelheim<\/h3>\n<ul>\n<li><strong>Estimated National TV Ad Spend:<\/strong> $15.8 million (up from $13.9 million in February)<\/li>\n<li><strong>Number of Spots:<\/strong> 3 (one CKD, two diabetes)<\/li>\n<li><strong>Biggest-ticket Ad:<\/strong> \u201cMusical: Store\u201d (Estimated spend: $11.2 million)<\/li>\n<\/ul>\n<h3>10. Vraylar by AbbVie<\/h3>\n<ul>\n<li><strong>Estimated National TV Ad Spend:<\/strong> $14.3 million (up from $8.9 million in February)<\/li>\n<li><strong>Number of Spots:<\/strong> 3 (one depression, two bipolar)<\/li>\n<li><strong>Biggest-ticket Ad:<\/strong> \u201cStuck in My Head: Basketball\u201d (Estimated spend: $11.2 million)<\/li>\n<\/ul>\n<h2>Conclusion<\/h2>\n<p>The pharmaceutical advertising landscape is undergoing a clear transformation as companies like Novo Nordisk and Johnson &#038; Johnson capitalize on significant cultural events to enhance exposure and engagement. With the advent of March Madness providing a compelling backdrop, it will be interesting to observe if these investment patterns will persist and influence overall sales trends in the health industry moving forward.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Novo\u2019s Wegovy, J&#038;J\u2019s Tremfya Boost TV Ad Spending During March Madness In a notable shift in advertising dynamics within the pharmaceutical sector, Novo Nordisk\u2019s publicity surge for its obesity treatment, Wegovy, alongside Johnson &#038; Johnson\u2019s enhanced spending for Tremfya, is indicative of a strategic pivot towards engaging audiences during the historically significant March Madness basketball&#8230;<\/p>\n","protected":false},"author":32,"featured_media":10373,"comment_status":"","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_eb_attr":"","footnotes":""},"categories":[685],"tags":[],"class_list":["post-10374","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-pharma-stocks"],"_links":{"self":[{"href":"https:\/\/wallstwarroom.com\/h\/wp-json\/wp\/v2\/posts\/10374","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/wallstwarroom.com\/h\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/wallstwarroom.com\/h\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/wallstwarroom.com\/h\/wp-json\/wp\/v2\/users\/32"}],"replies":[{"embeddable":true,"href":"https:\/\/wallstwarroom.com\/h\/wp-json\/wp\/v2\/comments?post=10374"}],"version-history":[{"count":0,"href":"https:\/\/wallstwarroom.com\/h\/wp-json\/wp\/v2\/posts\/10374\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/wallstwarroom.com\/h\/wp-json\/wp\/v2\/media\/10373"}],"wp:attachment":[{"href":"https:\/\/wallstwarroom.com\/h\/wp-json\/wp\/v2\/media?parent=10374"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/wallstwarroom.com\/h\/wp-json\/wp\/v2\/categories?post=10374"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/wallstwarroom.com\/h\/wp-json\/wp\/v2\/tags?post=10374"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}